NPS Pharmaceuticals, Inc. · Bedminster, NJ United States (NASDAQ: NPSP)
| 550 Hills Dr., 3rd Fl. | Phone: 908-450-5300 |
| Bedminster, NJ | |
| 07921 | |
| United States | 
Map This Company |
NPS Pharmaceuticals, Inc. Rankings
| Russell 2000 (June 2011) |
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Those suffering from intestinal failure are rooting for NPS Pharmaceuticals. The drug development company has a handful of candidates in development for gastrointestinal and endocrine disorders, with a focus on rare disorders with few available treatment options. One of its lead candidates, Gattex (teduglutide), is in clinical trials as a treatment for shortened bowel syndrome, a rare gastrointestinal disorder. Another, Natpara, is being studied as a treatment for a hormone deficiency disorder known as hyperparathyroidism. The company outsources much of its research; it also often partners with larger firms to help fund the late-stage development and commercialization of its drug candidates.
NPS Pharmaceuticals, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: NPSP Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 86 |
Executives
29 executives listed for NPS Pharmaceuticals, Inc.'s Bedminster, NJ location.
| Chairman | Peter Tombros | |
|---|---|---|
| President, CEO, and Director | François Nader | |
| SVP and CFO | Luke Beshar |